dapsone has been researched along with tyrosine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Diaz-Ruiz, A; Montes, S; Nava-Ruiz, C; Orozco-Suarez, S; Ortiz-Plata, A; Pérez-Neri, I; Perez-Severiano, F; Ríos, C; Salgado-Ceballos, H; Zavala, C | 1 |
| Bordin, L; Clari, G; Coleman, MD; Fiore, C; Ragazzi, E; Zen, F | 1 |
2 other study(ies) available for dapsone and tyrosine
| Article | Year |
|---|---|
Antioxidant, antiinflammatory and antiapoptotic effects of dapsone in a model of brain ischemia/reperfusion in rats.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Brain Ischemia; Caspase 3; Caspase 9; Chromatography, High Pressure Liquid; Dapsone; Immunoblotting; In Situ Nick-End Labeling; Lipid Peroxidation; Male; Neuroprotective Agents; Peroxidase; Rats; Rats, Wistar; Reperfusion Injury; Tyrosine | 2008 |
Dapsone hydroxylamine induces premature removal of human erythrocytes by membrane reorganization and antibody binding.
Topics: Anion Exchange Protein 1, Erythrocyte; Anti-Infective Agents; Antibodies; Dapsone; Dose-Response Relationship, Drug; Erythrocyte Membrane; Erythrocytes; Humans; Immunoglobulin G; Male; Middle Aged; Phosphorylation; Time Factors; Tyrosine | 2010 |